BookJean A. Klastersky, Consultant, Medical Oncology, Institut Jules Bordet, Centre des Tumeurs de l'Universite Libre de Bruxelles, Brussels, Belgium.
Contents:
1. Introduction
2. Prevention of febrile neutropenia
3. Prediction of the risk of complications associated with febrile neutropenia
4. Management of low-risk patients
5. Management of non-low-risk patients with febrile neutropenia
6. Management of persistent fever in patients with neutropenia despite empirical antibiotic administration
7. Costs associated with febrile neutropenia
8. At the extremes of age, febrile neutropenia in children and elderly